Avenue Therapeutics Inc [ATXI] stock prices are up 0.07% to $0.15 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ATXI shares have gain 6.68% over the last week, with a monthly amount glided 1.13%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 22, February 2024, Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy. In a post published today on Yahoo Finance, -In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell’s Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of absence epilepsy-.
From an analyst’s perspective:
The stock price of Avenue Therapeutics Inc [ATXI] has been fluctuating between $0.11 and $1.36 over the past year. Avenue Therapeutics Inc [NASDAQ: ATXI] shares were valued at $0.15 at the most recent close of the market.
Analyzing the ATXI fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -14.29, Equity is 4.39 and Total Capital is 3.61.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1469 points at the first support level, and at 0.1420 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1557, and for the 2nd resistance point, it is at 0.1596.
Avenue Therapeutics Inc [ATXI] reported earnings per share of $0.06 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.26/share, meaning a difference of $0.32 and a surprise factor of 123.10%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.52 per share as compared to estimates of -$0.29 per share, a difference of -$0.23 representing a surprise of -79.30%.
Ratios To Look Out For
It’s worth pointing out that Avenue Therapeutics Inc [NASDAQ:ATXI]’s Current Ratio is 0.04. As well, the Quick Ratio is 0.04, while the Cash Ratio is 0.03.
Transactions by insiders
Recent insider trading involved Davidow Robert L, 10% Owner, that happened on Dec 11 when 0.35 million shares were sold. 10% Owner, Davidow Robert L completed a deal on Dec 11 to sell 0.26 million shares. Meanwhile, 10% Owner Fortress Biotech, Inc. bought 0.42 million shares on Sep 08.
